CHINAPRIVATEEQUITYINVESTMENTHOLDINGSLIMITED

POSTINGOFADMISSIONDOCUMENT,NOTICEOFGENERALMEETING
ANDRESUMPTIONOFTRADING

Furthertotheannouncementon31December2013,CPEispleasedtoannouncethatithassigneda
conditionalAcquisitionAgreementwithElypsistoacquireinterestsinfourspecialpurposevehicles
which, in turn, hold interests in four domestic Chinese businesses. Elypsis is a wholly owned
subsidiary of Asia Private Credit Fund Limited, which is managed by an affiliate of Adamas Asset
Management.

DuetothesizeofthetransactioninrelationtotheCompany,theProposedAcquisitionconstitutesa
reversetakeoverundertheAIMRulesandrequiresapprovalbytheshareholdersoftheCompany.
TheAdmissionDocumentrelatingtotheProposedAcquisitionwillbepostedtoShareholderstoday
andisavailablefordownloadfromwww.cpeinvest.com.

The Admission Document incorporates notice of a General Meeting of the Company to be held at
180103, 18F, Tai Yau Building, 181 Johnston Road, Wanchai, Hong Kong at 8.00 a.m. (GMT)/4.00
p.m.(HKT)on18February2014.

Following the publication of the Admission Document, trading in the Ordinary Shares will
recommencewitheffectfrom8.00a.m.today.

TheProposals

PursuanttotheAcquisitionAgreement,CPEhasagreedtoacquireinterestsinfourspecial
purpose vehicles which hold interests in CJRE, Global Pharm, HKMH and Meize Energy,
furtherdetailsofwhicharesetoutbelow.

TheconsiderationfortheProposedAcquisitionwillbetheissuetoElypsisbytheCompany
of1,445,416,667newOrdinarySharesatapriceofUS$0.06perOrdinaryShare.Inaddition,
theCompanywillissuetoElypsiswarrantstosubscribefor722,708,333newOrdinaryShares
atUS$0.06pershareexercisablebetweenoneandsixyearsfollowingAdmission.

On Admission CPE Shareholders will be issued with new Bonus Shares on the basis of one
newOrdinaryShareforeverythreeOrdinarySharesheldbythemfornilconsideration.

CPE Shareholders will also receive warrants to subscribe for one new Ordinary Share for
everytwoOrdinarySharesheldbythem(excludingtheBonusIssue),exercisableatUS$0.06
persharewithin12monthsofAdmission.TherecorddatefortheBonusIssueandtheissue
ofwarrantswillbecloseofbusinessintheUKon18February2014.

The Company has entered into the Subscription Agreements with certain new investors,
conditional only on Admission, for the issue of an aggregate of 83,600,000 new Ordinary
SharesatapriceofUS$0.06,raisingUS$5.02million(approximately3.02million).

AresolutiontochangethenameoftheCompanyto'AdamasFinanceAsiaLimited'willbe
proposedattheGeneralMeeting.

Conditional on Admission, the Company has entered into a Services Agreement with
Adamas Global Alternative Investment Management Inc., which is an affiliate of Adamas
AssetManagement,toprovideinvestmentmanagementservicestotheCompanyinrespect
oftheassetsoftheEnlargedGroup.

ProposedAcquisition

PursuanttotheAcquisitionAgreement,theCompanyhasconditionallyagreedtoacquiretheissued
sharecapitalofLeadWinnerLimited,DynamiteWinLimitedandSwiftWealthInvestmentsLimited,
and75percent.oftheissuedsharecapitalofBlazerDelightLimited,whichholdindirectinterests,
respectively,inCJRE,HKMI,MeizeEnergyandGlobalPharm.

TheindirectintereststobeacquiredbytheCompanyareasfollows:

Company
Effective
Instrumenttype
Valuation*
Interest
US$million

CJRE
15%
Structuredequity
48.4
GlobalPharm
4.29%
Redeemableconvertiblebond
22.4
HKMI
5.68%
Structuredequity
9.9
6.7
MeizeEnergy
7.9%
Redeemableconvertiblepreferenceshares

Total

87.4

* ValuationsbyRomaAppraisalsLimitedasat31December2013

CJRE

CJREownsasubstantialresortandresidentialdevelopmentproject;theTianTongShanVillaProject
in Zhangzhou City, Fujian Province, China. The project is focused on a hot spring resort with
ancillaryresidential,commercialandrecreationalfacilities.Theprojectwastheonlyresortgranted
the title of Best Ecological Hot Spring Resort in Asia by World Real Estate Academy, China Real
EstateEnterprisesLeagueandWorldExecutiveGroupon28September2013.

GlobalPharm

Global Pharm is a pharmaceutical company headquartered in Shenzhen, China. The business

operates through three units, namely Traditional Chinese Medicine (TCM) herb cultivation, TCM
processinganddistributionandpharmaceuticaldistribution.

Global Pharm has appointed a tierone investment bank as lead arranger for an IPO on the Hong
KongStockExchangewhichistargetedtooccurinthefirsthalfof2014.

HKMH


HKMHs primary asset is a large dolomite magnesium limestone mine in the province of Shanxi,
China.HKMHisplanningtofileforanIPOontheHongKongStockExchangein2014.

MeizeEnergy

Meize Energy is a privatelyowned wind turbine blade design and manufacturing company. The
company'sproductsinclude1.5MWand2.0MWwindturbinebladeswiththe2.5MWversioninthe
researchanddevelopmentphase.

BonusIssueandWarrants

On Admission, the Company will allot and issue, for nil consideration, Bonus Shares to CPE
Shareholders on the basis of one new Bonus Share for every three Ordinary Shares held on the
RecordDate.EntitlementstoBonusShareswillberoundeddownandfractionalentitlementswillbe
ignored.

The Company will also issue, conditional on Admission, warrants to subscribe for new Ordinary
ShareswithanexercisepriceofUS$0.06pershare:

to existing Shareholders on the basis of one Shareholder Warrant for every two Ordinary
SharesheldbythemrespectivelyontheRecordDate,whicharecapableofexerciseatany
timewithin12monthsofAdmissiononthebasisofoneShareholderWarrantforeverytwo
Ordinary Shares held on the Record Date. Entitlements to Shareholder Warrants will be
roundeddownandfractionalentitlementswillbeignored;and

to Elypsis on the basis of one Consideration Warrant for every two Consideration Shares
issued to it pursuant to the Acquisition and which are capable of exercise at any time
betweenthedatesofthefirstandsixthanniversariesofAdmission.

Fundraising

TheCompanyhasenteredintotheSubscriptionAgreementswhich,conditionalonlyonAdmission,
willresultintheissueof83,600,000newOrdinarySharesatapriceofUS$0.06perOrdinaryShare,
raising US$5.02 million (approximately 3.02 million). Under the Subscription Agreements, the
subscription monies will be held in escrow pending Admission. The Company is required to
undertaketheFundraisingpursuanttoAIMRule8.

InvestingPolicy
FollowingAdmission,theInvestingPolicyoftheCompanywillbeasfollows:

Thetransactionswillbestructuredasseniordebt,bridgeloans,mezzaninefinanceandother
typesofstructuredprivatefinancing.

TargetcompanieswillbeSMEsinAsiawithafocusofGreaterChina.

The Company is generally sector agnostic, but will focus on agriculture, clean energy,
consumer,foodandbeverage,healthcare,newmaterials,realestateandresources.

Theaveragematurityofthetransactionswillrangefrom24to36months.

Eachnewassetwillhaveatargetedinternalrateofreturnof20percent.perannum.

The investment in each new asset will not represent more than 20 per cent. of the
Companysnetassetvalueimmediatelyfollowingthetransaction.

The Company has an indefinite life and is targeting both capital and income returns over
timeforitsshareholders.

Assets will be managed actively, including through appropriate investor protections which
willbenegotiatedoneachtransaction.

The Company is designed for investors seeking access to yieldproducing investment

opportunitiesinAsia.

TheCompanywillnotusedebttofinanceindividualinvestments,butmaytakeondebtat
theCompanylevelwithnospecificlimit.

ServicesAgreement

TheCompanyandAdamasGAIMenteredintoaServicesAgreementon29January2014pursuantto
which, conditional on Admission, Adamas GAIM has been given sole responsibility for the
managementoftheCompany'sassetsinaccordancewiththeCompany'sinvestingpolicy,subjectto
theoverallcontrolandsupervisionoftheDirectors.

AdamasGAIMisentitledtoreceivefromtheCompany,inrespectofitsservicesprovidedunderthe
Services Agreement, a management fee which is calculated and paid biannually in advance
calculatedatthehigherofeitheranannualrateofonepercent.ofthehigherofnetassetvalueof
theCompany'sportfolioofassets,calculatedontherelevanthalfyeardate(beingeither30Juneor
31 December), or one per cent. of the market capitalisation of the Ordinary Shares. The Services
Agreementisforaninitialtermofthreeyears,thereafterbeingterminableupon12months'written
notice.TheServicesAgreementissubjecttoearlierterminationinspecifiedcircumstances.

Board

ThecurrentDirectorsandtheirtitlesare:

JohnCroft(ExecutiveChairman)
ConorMacNamara(NonExecutiveDirector)
ErnestWong(ExecutiveDirector)

With effect from Admission and the commencement of the Services Agreement, John Croft will
becomeNonExecutiveChairmanandErnestWongwillbecomeaNonExecutiveDirector.

IrrevocableUndertakings

The Company has received irrevocable undertakings to vote in favour of the resolutions to be
proposed at the General Meeting in respect of holdings totalling 36,982,516 Ordinary Shares,

representing29.3percent.oftheissuedsharecapital,includinganundertakingfromJohnCroft,the
onlyDirectorwhoholdsOrdinaryShares,inrespectofhisholdingof254,590OrdinaryShares.

AdmissionStatistics

NumberofExistingOrdinaryShares
126,284,645
NumberofBonusShares

upto42,094,881

NumberofConsiderationShares

1,445,416,667
83,600,000

NumberofSubscriptionShares
NumberofOrdinarySharesinissueonAdmission

upto1,697,396,193

ConsiderationSharesasapercentageoftheEnlargedShareCapital

85.2percent.

NumberofShareholderWarrants

upto63,142,322

NumberofConsiderationWarrants

722,708,333

NumberofoutstandingWarrantsandOptionsonAdmission(includingthe
ShareholderWarrantsandtheConsiderationWarrants)
ISINonAdmission
AIMtickerfromAdmission

upto788,100,655

VGG008271089
ADAM

ExpectedTimetableofPrincipalEvents
PublicationoftheAdmissionDocument

30January2014

Latesttimeanddateforreceiptofformsofinstructionfrom
holdersofdepositaryinterestsfortheGeneralMeeting

8.00a.m.(GMT)/4.00p.m.(HKT)
on15February2014

Latesttimeanddateforreceiptofthecompletedformsofproxy
tobevalidattheGeneralMeeting

8.00a.m.(GMT)/4.00p.m.(HKT)
on16February2014

GeneralMeeting

8.00a.m.(GMT)/4.00p.m.(HKT)
on 18February2014

RecordDate

closeofbusinessintheUKon18
February2014

Completion of the Acquisition, Fundraising, Admission and

commencementofdealingsonAIMintheEnlargedIssuedShare
Capital

8.00a.m.on 19February2014

CREST accounts credited with Bonus Shares and Fundraising

19February2014

Shares

AllreferencestotimesinthisannouncementaretoUKtimeunlessotherwisestated.
Save for the date of publication of the Admission Document, each of the times and dates above is
subject to change. Any such change, including any consequential change in the Admission statistics
above,willbenotifiedtoShareholdersbyanannouncementonaRegulatoryInformationService.

Enquiries:

ChinaPrivateEquityInvestmentHoldingsLtd
JohnCroft

NominatedAdviser
WHIrelandLimited
TimFeather

Broker
LaurelCapitalKingswayLLP
SuniGoonetillake

PublicRelationsAdvisers
FirstCityPublicRelations(HongKong)
AllanPiper

TavistockCommunications(London)
SimonHudson

+44(0)1825830587

+44(0)1133946611

+44(0)2033300928

+85228542666

+44(0)2079203170

Definitions

Thefollowingdefinitionsapplyinthisannouncementunlessthecontextotherwiserequires:

Acquisition
theproposedacquisitionbytheCompanyofthewholeoftheissued
sharecapitalofeachofLeadWinnerLimited,DynamiteWinLimited
andSwiftWealthInvestmentsLimited,togetherwith75percent.of
theissuedsharecapitalofBlazerDelightLimited

AcquisitionAgreement
the conditional agreement dated 29 January 2014 between the
CompanyandElypsisinrespectoftheAcquisition

AdamasAsset
AdamasAssetManagement(HK)Limited
Management

Admission

AdmissionDocument

AIM

AIMRules

BonusIssue

BonusShares

CJRE

CompanyorCPE

ConsiderationShares

ConsiderationWarrants

CPEShareholder(s)

Elypsis

EnlargedGroup

EnlargedShareCapital

Fundraising

GeneralMeeting

GlobalPharm

"GMT"

HKMH

admissionoftheEnlargedShareCapitaltotradingonAIMandsuch
admissionbecomingeffectiveinaccordancewithRule6ofthe AIM
Rules

theadmissiondocumentrelatingtotheEnlargedGrouppreparedin
accordance with the AIM Rules by the Company being posted to
Shareholderstoday

theAIMmarketoperatedbytheLondonStockExchange

the AIM Rules for Companies published by the London Stock

Exchange,asamendedfromtimetotime

the issue on Admission of new Ordinary Shares to Shareholders on

thebasisofonenewOrdinaryShareforeverythreeOrdinaryShares
heldatthecloseofbusinessontheRecordDate

anaggregateofupto42,094,881newOrdinarySharestobeissued
pursuanttotheBonusIssue

ChangtaiJinhongbangRealEstateDevelopmentCo.Ltd

ChinaPrivateEquityInvestmentHoldingsLimited

the 1,445,416,667 new Ordinary Shares to be issued to Elypsis

pursuanttotheAcquisitionAgreement

the 722,708,333 warrants to subscribe for Ordinary Shares to be

issuedtoElypsispursuanttotheAcquisitionAgreement

holder(s)ofOrdinaryShares

ElypsisSolutionsLimited

the Company and its subsidiaries following completion of the

ProposedAcquisition

theissuedsharecapitaloftheCompanyonAdmission

thesubscriptionsfor83,600,000newOrdinarySharesconditionalon
AdmissionpursuanttotheSubscriptionAgreements

thegeneralmeetingoftheCompanytobeheldon18February2014,
noticeofwhichissetoutintheAdmissionDocument

GlobalPharmHoldingsGroupInc.

GreenwichMeanTime

HongKongMiningHoldingsLimited

HKT

MeizeEnergy

NameChange

OrdinaryShares

Proposals

RecordDate

ShareholderWarrants

SubscriptionAgreements

HongKongtime

MeizeEnergyIndustriesHoldings

thechangeofnameoftheCompanytoAdamasFinanceAsiaLimited
tobeproposedattheGeneralMeeting

ordinarysharesofnoparvalueinthecapitaloftheCompany

theAcquisition,Fundraising,theNameChangeandAdmission

closeofbusinesson18February2014

up to 42,094,881 warrants to be issued to CPE Shareholders on

Admission

the agreements dated 29 January 2014 between the Company and

certaininvestorsrelatingtotheFundraising

UnitedStatesdollars

US$

Anexchangerateof1:US$1.66hasbeenusedinthisannouncement.